These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 19652480

  • 21. Markers of oxidative stress in dogs with heart failure.
    Verk B, Nemec Svete A, Salobir J, Rezar V, Domanjko Petrič A.
    J Vet Diagn Invest; 2017 Sep; 29(5):636-644. PubMed ID: 28580831
    [Abstract] [Full Text] [Related]

  • 22. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
    Feringa HH, Poldermans D, Klein P, Braun J, Klautz RJ, van Domburg RT, van der Laarse A, van der Wall EE, Dion RA, Bax JJ.
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
    [Abstract] [Full Text] [Related]

  • 23. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
    Kanno N, Hori Y, Hidaka Y, Chikazawa S, Kanai K, Hoshi F, Itoh N.
    J Vet Med Sci; 2016 May 03; 78(4):535-42. PubMed ID: 26607133
    [Abstract] [Full Text] [Related]

  • 24. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
    Boswood A, Dukes-McEwan J, Loureiro J, James RA, Martin M, Stafford-Johnson M, Smith P, Little C, Attree S.
    J Small Anim Pract; 2008 Jan 03; 49(1):26-32. PubMed ID: 18005104
    [Abstract] [Full Text] [Related]

  • 25. The cardiac biomarker NT-proBNP is increased in dogs with azotemia.
    Raffan E, Loureiro J, Dukes-McEwan J, Fonfara S, James R, Swift S, Bexfield N, Herrtage ME, Archer J.
    J Vet Intern Med; 2009 Jan 03; 23(6):1184-9. PubMed ID: 19709357
    [Abstract] [Full Text] [Related]

  • 26. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR, Rush JE, Reynolds CA, Defrancesco TC, Keene BW, Atkins CE, Gordon SG, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Macdonald KA, Lehmkuhl LB, Nguyenba TP, Sydney Moise N, Lefbom BK, Hogan DF, Oyama MA.
    J Vet Intern Med; 2011 Jan 03; 25(5):1010-6. PubMed ID: 21985136
    [Abstract] [Full Text] [Related]

  • 27. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
    Schmidt MK, Reynolds CA, Estrada AH, Prosek R, Maisenbacher HW, Sleeper MM, Oyama MA.
    J Vet Cardiol; 2009 May 03; 11 Suppl 1():S81-6. PubMed ID: 19394913
    [Abstract] [Full Text] [Related]

  • 28. Plasma adrenomedullin concentration in dogs with myxomatous mitral valvular disease.
    Kanno N, Asano K, Teshima K, Seki M, Edamura K, Uechi M, Tanaka S.
    J Vet Med Sci; 2012 Jun 03; 74(6):739-43. PubMed ID: 22240987
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease.
    Fine DM, DeClue AE, Reinero CR.
    J Am Vet Med Assoc; 2008 Jun 01; 232(11):1674-9. PubMed ID: 18518809
    [Abstract] [Full Text] [Related]

  • 30. Plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with pulmonic stenosis.
    Kobayashi K, Hori Y, Chimura S.
    J Vet Med Sci; 2014 Jun 01; 76(6):827-31. PubMed ID: 24561377
    [Abstract] [Full Text] [Related]

  • 31. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.
    Oyama MA, Rush JE, Rozanski EA, Fox PR, Reynolds CA, Gordon SG, Bulmer BJ, Lefbom BK, Brown BA, Lehmkuhl LB, Prosek R, Lesser MB, Kraus MS, Bossbaly MJ, Rapoport GS, Boileau JS.
    J Am Vet Med Assoc; 2009 Dec 01; 235(11):1319-25. PubMed ID: 19951101
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
    Haßdenteufel E, Kresken JG, Henrich E, Hildebrandt N, Schneider C, Stosic A, Schneider M.
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Dec 01; 40(3):171-9. PubMed ID: 22688794
    [Abstract] [Full Text] [Related]

  • 34. The diagnostic significance of the plasma N-terminal pro-B-type natriuretic Peptide concentration in asymptomatic cats with cardiac enlargement.
    Tominaga Y, Miyagawa Y, Toda N, Takemura N.
    J Vet Med Sci; 2011 Aug 01; 73(8):971-5. PubMed ID: 21467762
    [Abstract] [Full Text] [Related]

  • 35. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease.
    Hezzell MJ, Boswood A, Chang YM, Moonarmart W, Souttar K, Elliott J.
    J Vet Intern Med; 2012 Aug 01; 26(2):302-11. PubMed ID: 22369312
    [Abstract] [Full Text] [Related]

  • 36. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G, Daisenberger P, Mahling M, Hirschberger J, Hartmann K.
    Vet Clin Pathol; 2011 Jun 01; 40(2):237-44. PubMed ID: 21434959
    [Abstract] [Full Text] [Related]

  • 37. Usefulness of NT-proBNP in the assessment of patients with aortic or mitral regurgitation.
    Petracca F, Affuso F, Di Conza P, Micillo F, Castellano G, Guardasole V, Scopacasa F, Saccà L, Fazio S.
    J Cardiovasc Med (Hagerstown); 2009 Dec 01; 10(12):928-32. PubMed ID: 19606057
    [Abstract] [Full Text] [Related]

  • 38. [Value of plasma NT-proBNP for diagnosing heart failure in patients with previous myocardial infarction].
    Wei BQ, Zhang J, Yang YJ, Lü R, Zhang YH, Zhou Q, Gao RL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jan 01; 40(1):34-8. PubMed ID: 22490631
    [Abstract] [Full Text] [Related]

  • 39. Weekly variability of plasma and serum NT-proBNP measurements in normal dogs.
    Kellihan HB, Oyama MA, Reynolds CA, Stepien RL.
    J Vet Cardiol; 2009 May 01; 11 Suppl 1():S93-7. PubMed ID: 19395335
    [Abstract] [Full Text] [Related]

  • 40. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.
    J Vet Cardiol; 2009 May 01; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.